Clinical Trials In Anaheim

Discover hundreds of clinical trials in Anaheim.
Search clinical trials in Anaheim by condition or phase.

e.g. Respiratory Diseases

Anaheim•Healthy volunteers: No

Filter results

Results: 3,433

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Recruiting

Phase 1

Phase 2

Sponsor:

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Location:

San Francisco, Los Angeles, Aurora, Bostonshow 7 more

Code:

NCT04471727

Conditions

Small-Cell Lung Cancer

Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-6070

Atezolizumab

Ifinatamab Deruxtecan (I-DXd)

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Recruiting

Phase 3

Sponsor:

IBSA Institut Biochimique SA

Location:

La Palma, Little Rock, Bradenton, DeLandshow 12 more

Code:

NCT05171673

Conditions

Soft Tissue Injuries

Eligibility Criteria

Sex: All

Age: 6 - 45

Healthy Volunteers: Not accepted

Interventions

Licart™ (diclofenac epolamine) topical system

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Woodland Hills, Torrance, Thousand Oaks, San Diegoshow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Los Angeles, Phoenix, Little Rock, Aurorashow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Victorville, Temecula, San Diego, Murrietashow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Recruiting

Phase 2

Sponsor:

Teclison Ltd.

Location:

Orange

Code:

NCT04701476

Conditions

Colorectal Cancer; Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TATE and pembrolizumab

TAS-102 pill

Regorafenib Pill

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Recruiting

Sponsor:

Beacon Biosignals

Location:

Redwood City, Fontana, Rochester, Cincinnati

Code:

NCT06531876

Conditions

Narcolepsy Type 1

Hypersomnia

Sleep Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dreem 3S recording

A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)

Recruiting

Phase 2

Phase 3

Sponsor:

ALX Oncology Inc.

Location:

Anaheim, Los Angeles, Nashville, Fairfaxshow 1 more

Code:

NCT05002127

Conditions

Gastric Cancer

Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evorpacept (ALX148)

Trastuzumab

Ramucirumab

Paclitaxel

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

Phase 3

Sponsor:

Intec Pharma Ltd.

Location:

Reseda, Pasadena, Los Angeles, Loma Lindashow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Recruiting

Sponsor:

Jonsson Comprehensive Cancer Center

Location:

Los Angeles

Code:

NCT06387173

Conditions

Early Stage Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Non-Interventional Study

e.g. Respiratory Diseases

Anaheim•Healthy volunteers: No

Filter results

Results: 3,433

A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001)

Recruiting

Phase 1

Phase 2

Sponsor:

Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Location:

San Francisco, Los Angeles, Aurora, Bostonshow 7 more

Code:

NCT04471727

Conditions

Small-Cell Lung Cancer

Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MK-6070

Atezolizumab

Ifinatamab Deruxtecan (I-DXd)

Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury

Recruiting

Phase 3

Sponsor:

IBSA Institut Biochimique SA

Location:

La Palma, Little Rock, Bradenton, DeLandshow 12 more

Code:

NCT05171673

Conditions

Soft Tissue Injuries

Eligibility Criteria

Sex: All

Age: 6 - 45

Healthy Volunteers: Not accepted

Interventions

Licart™ (diclofenac epolamine) topical system

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Woodland Hills, Torrance, Thousand Oaks, San Diegoshow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Los Angeles, Phoenix, Little Rock, Aurorashow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Victorville, Temecula, San Diego, Murrietashow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Recruiting

Phase 2

Sponsor:

Teclison Ltd.

Location:

Orange

Code:

NCT04701476

Conditions

Colorectal Cancer; Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TATE and pembrolizumab

TAS-102 pill

Regorafenib Pill

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Recruiting

Sponsor:

Beacon Biosignals

Location:

Redwood City, Fontana, Rochester, Cincinnati

Code:

NCT06531876

Conditions

Narcolepsy Type 1

Hypersomnia

Sleep Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dreem 3S recording

A Study of Evorpacept (ALX148) in Patients with Advanced HER2+ Gastric Cancer (ASPEN-06)

Recruiting

Phase 2

Phase 3

Sponsor:

ALX Oncology Inc.

Location:

Anaheim, Los Angeles, Nashville, Fairfaxshow 1 more

Code:

NCT05002127

Conditions

Gastric Cancer

Gastroesophageal Junction Adenocarcinoma

Gastric Adenocarcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evorpacept (ALX148)

Trastuzumab

Ramucirumab

Paclitaxel

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

Phase 3

Sponsor:

Intec Pharma Ltd.

Location:

Reseda, Pasadena, Los Angeles, Loma Lindashow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Recruiting

Sponsor:

Jonsson Comprehensive Cancer Center

Location:

Los Angeles

Code:

NCT06387173

Conditions

Early Stage Breast Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Non-Interventional Study